Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
The new approach, which features a heat-sensitive fluorescent dye, could eventually replace standard chemotherapy.
By analyzing tumors, Foundation Medicine helps oncologists, pharma companies, and researchers combat the disease.
Tumors closer to committing “cellular suicide” are more sensitive to conventional anticancer drugs.
Researchers hope to combine the sensor with a device to deliver targeted chemotherapy.
The experimental therapy could ultimately serve as a seek-and-destroy treatment for metastatic cancer.
Those with higher levels of a particular molecule were found to be more likely to die of heart disease or cancer in the next dozen years.
Researchers are developing more and more genetic tests for specific cancers, but doctors don’t use them as often as they should—a new network of clinics aims to change that.
A startup is developing the first vaccine to target patients before they develop cancer.
Immune therapy proves effective against melanoma in an early trial.